Gabapentin, Phenobarbital, Diazepam, and Lorazepam for the Treatment of Alcohol Withdrawal: Clinical Effectiveness and Guidelines

Details

Files
Project Status:
Completed
Project Line:
Reference List
Project Sub Line:
Summary of Abstracts
Project Number:
RB1498-000

Question

  1. What is the clinical effectiveness of gabapentin, phenobarbital, diazepam, and lorazepam for the management of individuals with alcohol withdrawal?
  2. What are the evidence-based guidelines regarding the management of individuals with alcohol withdrawal in the emergency department?
  3. What are the evidence-based guidelines regarding the provision of addiction services to vulnerable populations with alcohol withdrawal during the coronavirus pandemic?

Key Message

Two systematic reviews and eleven non-randomized studies were identified regarding the clinical effectiveness of gabapentin, phenobarbital, diazepam, and lorazepam for the management of individuals with alcohol withdrawal. Four evidence-based guidelines were identified regarding the management of individuals with alcohol withdrawal in the emergency department. No relevant evidence-based guidelines were identified regarding the provision of addiction services to vulnerable populations with alcohol withdrawal during the coronavirus pandemic.